Navigation Links
Aggressive Therapy May Stem CF Progression in Infants
Date:12/5/2008

Treating cystic fibrosis in first 6 months appears most effective, Australian study finds

FRIDAY, Dec. 5 (HealthDay News) -- It may be possible to control the progression of cystic fibrosis through early detection and aggressive treatment of the disease in infants, according to Australian researchers.

They found that progressive lung damage in CF patients can start as early as infancy, even though lung function shortly after diagnosis is normal. The finding challenges current scientific belief.

The study included 68 infants with CF, ages 6 weeks to 30 months, who were compared to a control group of 49 infants without the disease. At 6 months of age, infants with CF had significantly poorer lung function than those in the control group, and that difference increased with each month of age. This shows that lung function in infants with CF declines sooner than previously thought, the researchers said.

They also found that diminished lung function occurred even when there were no clinical symptoms and irrespective of CF genotype.

The most significant finding was that infants with CF had normal lung function test results shortly after birth and within their first six months of life, the researchers said.

"We might be able to stop some of the lung function reduction we're identifying in the first months of life," study author Dr. Sarath Ranganathan, a consultant respiratory physician at the Royal Children's Hospital in Melbourne, said in an American Thoracic Society news release. "We don't know what's going to work, but we have to target those patients in the first six months of life if we're going to be effective."

The study, published in the second issue for December of the American Journal of Respiratory and Critical Care Medicine, validates the early-screening approach used in Australia and indicates that other nations should adopt similar programs, the researchers said.

'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. MedPro Imaging Continues Aggressive U.S. Expansion
2. Women with mitral valve prolapse are treated less aggressively than men and may be at high risk
3. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
4. Less Exposure to Violent Media Makes Youths Less Aggressive
5. Professional Sports Teams Should Use MRSA Screening and Other Aggressive Methods to Prevent Staph Infections
6. American Association for Homecare Proposes Aggressive 13-Point Plan to Stop Medicare Fraud and Recoup Billions; Calls Steps Essential to Medicares Health
7. Move over mean girls -- boys can be socially aggressive, too
8. Cord Blood America CEO Announces Aggressive Acquisition Strategy, Increased Investor Relations Efforts, New Stem Cell Storage Models
9. PSA screening may be biased against obese men, leading to more aggressive cancers
10. Aggressive preschoolers found to have fewer friends than others
11. Cord Blood America CEO Matthew Schissler Details Aggressive Expansion Strategies in U.S. and Europe
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aggressive Therapy May Stem CF Progression in Infants
(Date:5/20/2013)... University of Southampton has shown that blind and visually ... to that used by bats and dolphins, to determine ... is published in the journal Hearing Research , ... could help blind people with spatial awareness and navigation. ... impairment and how to optimise echolocation ability in order ...
(Date:5/20/2013)... 6Webs.com is the leading supplier of ... 6Webs.com recently completed their assessments of the top alarm ... annually and the top home security system companies are ... technology, equipment and warranties to mention a few. ... team completed the home security reviews, numerous people claimed ...
(Date:5/20/2013)... Dermatologists are saying that new federally mandated labeling ... choices when it comes to products that provide ... required by the U.S. Food and Drug Administration ... will protect against skin cancer in addition to ... a sunscreen is water-resistant, according to the American ...
(Date:5/20/2013)... VHA Inc., the national health care ... population health improvement, announced a new offering to ... pursue population health management with a strategic ... the transition to value-based models of care. As ... of services, the offering integrates VHA expert advisory ...
(Date:5/20/2013)... Researchers at Lund University in Sweden have mapped ... atherosclerotic disease. No studies have previously examined whether ... study looked at coronary heart disease, ischemic stroke, ... in individuals whose siblings and parents have suffered ... showed that heredity is highest for atherosclerosis of ...
Breaking Medicine News(10 mins):Health News:New study finds blind people have the potential to use their 'inner bat' to locate objects 2Health News:Best Home Alarm System Companies in 2013 Published by Leading Security Reviews Site - 6Webs.com 2Health News:Revised Sunscreen Labels Should Help Consumers Make Wiser Choices 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4
... MKL ) reported diluted net loss per share ... to diluted net income per share of $9.26,for the ... was $2.63 for the,nine months ended September 30, 2008 ... the same period of 2007. The results for both ...
... more targeted prevention efforts, researcher says , , TUESDAY, Nov. 4 ... Hispanics in the United States, a new study shows. , ... a type of beverage that is more associated with risky ... developed to target that beverage and that type of drinking," ...
... HAVEN, Conn., Nov. 4 VION,PHARMACEUTICALS, INC. (OTC Bulletin ... on Thursday, November 6, 2008 to,discuss its 2008 third ... 8:30 a.m. Eastern Time., To participate in the ... 213-8858 for international callers), at least 15 minutes,before the ...
... 4, 2008 Proactive measures can reduce hip fracture rates ... as 50 percent -- among those at risk, according to ... was published online on November 3 by The Journal ... , The largest study of its kind, the five-year study ...
... be Held at 8 a.m. EST -, SHENZHEN, ... (NYSE: NPD ) ("China Nepstar" or the "Company"), ... of directly operated,stores, announced today that the Company will ... before the market opens on,Wednesday, November 26, 2008., ...
... (Nasdaq: IRIX ) today reported financial results for ... the third quarter of 2008 was $12.0 million, an ... quarter of 2007. The,Company recorded net loss of $0.2 ... of 2008, an improvement over the net loss of ...
Cached Medicine News:Health News:Markel Reports Third Quarter and Nine-Month Results 2Health News:Markel Reports Third Quarter and Nine-Month Results 3Health News:Markel Reports Third Quarter and Nine-Month Results 4Health News:Study Shows Hispanics Prefer Beer 2Health News:Vion Updates Conference Call Information 2Health News:Vion Updates Conference Call Information 3Health News:Healthy bones program reduces hip fractures by 37 percent 2Health News:China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26 2Health News:China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26 3Health News:IRIDEX Reports Third Quarter 2008 Financial Results 2Health News:IRIDEX Reports Third Quarter 2008 Financial Results 3Health News:IRIDEX Reports Third Quarter 2008 Financial Results 4Health News:IRIDEX Reports Third Quarter 2008 Financial Results 5Health News:IRIDEX Reports Third Quarter 2008 Financial Results 6
(Date:5/20/2013)... , May 20, 2013 Hyland ... healthcare industry by creating the Multi-Disciplinary Clinical Leadership ... variety of medical experts with diverse healthcare experience, ... healthcare industry to create new software solutions that ... specific needs of patients and staff. ...
(Date:5/20/2013)... 20, 2013 Enrollment of patients with Type ... dose-finding clinical trial of product candidate NewMet ™, ... for Type 2 diabetes. Elcelyx expects to complete enrollment ... June. Results of the trial,s primary endpoint of change ... and the read-out for long-term glucose lowering and weight ...
(Date:5/20/2013)...  Rhythm announced today the presentation of results from ... gastroparesis symptoms among diabetic patients in the U.S. than ... patients with both type 1 and type 2 diabetes, ... the more common type 2 disease. ... Professor of Medicine at Harvard Medical School and Director ...
Breaking Medicine Technology:Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
... IMMULITE 1000 assays are designed ... and IMMULITE 1000, continuous random ... simplicity in both design and ... found in a wide variety ...
... Digoxin Assay is a homogeneous ... in the quantitative analysis of ... plasma. Kits are packaged specifically ... COBAS MIRA, COBAS MIRA S, ...
The Emit 2000 Digoxin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of digoxin in human serum or plasma. Kits are conveniently packaged in Olympus Reagent Cartridges ...
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
Medicine Products: